Sort
38,696 grants matching “als”
Collaborative Research: Impact of the Summer Institutes on Faculty Teaching and Student Achievement
$572,235William M Trochim · Cornell University · · FY2014 · EDU
Preservation of muscle function through Schwann cell regulation of motor unit expansion
$572,203Susan V Brooks · University Of Michigan At Ann Arbor · R01 · FY2024 · AG
Investigation of UBQLN2 in neuronal dysfunction and ALS-FTD
$572,190Alexandra Whiteley · University Of Colorado · R01 · FY2023 · NS
Function and Pathogenic Mechanism of LRRK2 in Parkinson's Disease
$572,150Huaibin Cai · National Institute On Aging · ZIA · FY2017 · AG
Reducing Injury, ETOH &THC Use among ED Patients
$572,146Rhode Island Hospital · R01 · FY2004 · AA
G Protein-Coupled Receptor Regulation in Airway Myocytes
$572,142Raymond B. Penn · Thomas Jefferson University · R01 · FY2024 · HL
The Senior Odyssey: A Test of the Engagement Hypothesis of Cognitive Aging
$572,137Elizabeth A L Stine-Morrow · University Of Illinois At Urbana-Champaign · R01 · FY2007 · AG
Unruptured Intracranial Aneurysms: Rupture-Risk Assessment by Non-Invasive Molecular Imaging
$572,092Alexei A Bogdanov · Univ Of Massachusetts Med Sch Worcester · R01 · FY2015 · NS
NEWBORN SCREENINGS FOR PILOT STUDY FOR ADRENOLEUKODYSTROPHY (ALD)
$572,048Don Bailey · Research Triangle Institute · N01 · FY2016 · HD
In Vivo Detection of Free Radical Generation
$572,013Ronald P Mason · National Institute Of Environmental Health Sciences · ZIA · FY2018 · ES
Dynamics of Kinesins, Dyneins, and Myosins
$572,003Paul R Selvin · University Of Illinois At Urbana-Champaign · R01 · FY2006 · AR
Diffraction From Microvolume Topaz Microprocessors
$571,974Andrew Paul May · Fluidigm Corporation · R42 · FY2006 · GM
Regulation of T cell Differentiation
$571,939Warren Strober · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
The mechanism of allosteric modulation of glutamate transporters
$571,908Andreia C K Mortensen · Drexel University · R01 · FY2023 · NS
Eradicating persistent M. tuberculosis by synthetic lethality of terminal respiratory oxidases
$571,898Michael Berney · Albert Einstein College Of Medicine · R01 · FY2019 · AI
Mechanisms of Tumor Cell Dormancy and Tumor Recurrence
$571,893Jeffrey E Green · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Evaluation of Oral Tobacco as a Harm Reduction Method for Smokers
$571,855Dorothy K Hatsukami · University Of Minnesota · R01 · FY2009 · CA
Fgl2 neutralizing therapy for inducing tumor specific brain resident immune memory against CNS tumor relapse
$571,813Shulin Li · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · NS
Uncovering treatment targets for peripheral nerve sheath tumor progression in NF1
$571,785David Andrew Largaespada · University Of Minnesota · R01 · FY2023 · NS
A trial of Connecting to prevent drug abuse and risky behaviors in foster teens
$571,779Kevin P Haggerty · University Of Washington · R01 · FY2017 · DA
Mechanisms of Viral Pathogenesis in the Central Nervous System
$571,625Karin Peterson · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Enhancing PrEP outcomes among Kenyan adolescent girls and young women with a novel pharmacy-based PrEP delivery platform
$571,612Jillian Pintye · University Of Washington · R01 · FY2022 · HD
Calcium and the Pathophysiology of Neurodegenerative Disorders
$571,456Andrew R Marks · Columbia University Health Sciences · R01 · FY2024 · NS
Family-to-Family: Psychoeducation to Improve Children's Outcomes in HIV+ Families
$571,380Li Li · University Of California Los Angeles · R01 · FY2009 · NR
Pre-clinical and clinical studies of NTBC and other compounds as potential treatments for albinism
$571,375Brian Brooks · National Eye Institute · ZIA · FY2018 · EY